<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="de">
	<id>https://h.suprapedia.de/w/index.php?action=history&amp;feed=atom&amp;title=Statistik_und_Studiendesign</id>
	<title>Statistik und Studiendesign - Versionsgeschichte</title>
	<link rel="self" type="application/atom+xml" href="https://h.suprapedia.de/w/index.php?action=history&amp;feed=atom&amp;title=Statistik_und_Studiendesign"/>
	<link rel="alternate" type="text/html" href="https://h.suprapedia.de/w/index.php?title=Statistik_und_Studiendesign&amp;action=history"/>
	<updated>2026-06-07T16:02:21Z</updated>
	<subtitle>Versionsgeschichte dieser Seite in PlusPedia</subtitle>
	<generator>MediaWiki 1.43.3</generator>
	<entry>
		<id>https://h.suprapedia.de/w/index.php?title=Statistik_und_Studiendesign&amp;diff=958425&amp;oldid=prev</id>
		<title>Fmrauch: zu allgemein</title>
		<link rel="alternate" type="text/html" href="https://h.suprapedia.de/w/index.php?title=Statistik_und_Studiendesign&amp;diff=958425&amp;oldid=prev"/>
		<updated>2024-11-19T19:48:46Z</updated>

		<summary type="html">&lt;p&gt;zu allgemein&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;de&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Nächstältere Version&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Version vom 19. November 2024, 19:48 Uhr&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Zeile 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Zeile 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Statistik&amp;#039;&amp;#039;&amp;#039; und &amp;#039;&amp;#039;&amp;#039;Studiendesign&amp;#039;&amp;#039;&amp;#039; sind wesentliche Grundlagen in vielen Bereichen wissenschaftlicher Forschung. Die gilt insbesondere in den [[Naturwissenschaft]]en.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Statistik&amp;#039;&amp;#039;&amp;#039; und &amp;#039;&amp;#039;&amp;#039;Studiendesign&amp;#039;&amp;#039;&amp;#039; sind wesentliche Grundlagen in vielen Bereichen wissenschaftlicher Forschung. Die gilt insbesondere in den [[Naturwissenschaft]]en.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Freie Übersichtsartikel ...&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Freie Übersichtsartikel ...&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;ref name=&quot;PMID18755930&quot;&amp;gt;When is a negative phase II trial truly negative? Am J Respir Crit Care Med 178(6):554-5 (2008) PMID 18755930 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID15590885&quot;&amp;gt;The ethical conduct of clinical research involving critically ill patients in the United States and Canada: principles and recommendations. Am J Respir Crit Care Med 170(12):1375-84 (2004) PMID 15590885 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID15151921&quot;&amp;gt;Positive clinical trials: understand the control group before implementing the result. Am J Respir Crit Care Med 170(3):223-6 (2004) PMID 15151921 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID9424990&quot;&amp;gt;Number needed to treat and relative risk reduction. Ann Intern Med 128(1):72-3 (1998) PMID 9424990 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID7486471&quot;&amp;gt;Discordance between meta-analyses and large-scale randomized, controlled trials. Examples from the management of acute myocardial infarction. Ann Intern Med 123(11):873-7 (1995) PMID 7486471 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID16040886&quot;&amp;gt;Understanding systematic reviews and meta-analysis. Arch Dis Child 90(8):845-8 (2005) PMID 16040886 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID15102650&quot;&amp;gt;GRADE: levels of evidence and grades of recommendation. Arch Dis Child 89(5):489 (2004) PMID 15102650 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID7492177&quot;&amp;gt;Statistics from the inside. 16. Multiple regression (2). Arch Dis Child 73(3):270-4 (1995) PMID 7492177 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID8067802&quot;&amp;gt;Statistics from the inside. 13. Probability and decisions. Arch Dis Child 71(1):90-4 (1994) PMID 8067802 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID8333779&quot;&amp;gt;10. Counted data (2). Arch Dis Child 68(6):800-2 (1993) PMID 8333779 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID8481051&quot;&amp;gt;Counted data (1). Arch Dis Child 68(2):246-9 (1993) PMID 8481051 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID1444537&quot;&amp;gt;Statistics from the inside. 7. Regression and correlation. Arch Dis Child 67(10):1306-9 (1992) PMID 1444537 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID1626999&quot;&amp;gt;Statistics from the inside. 6. Data structures (continued). Arch Dis Child 67(6):757-9 (1992) PMID 1626999 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17296672&quot;&amp;gt;Documenting research in scientific articles: Guidelines for authors: 3. Reporting multivariate analyses. Chest 131(2):628-32 (2007) PMID 17296672 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17218594&quot;&amp;gt;Documenting research in scientific articles: guidelines for authors: 2. Reporting hypothesis tests. Chest 131(1):317-9 (2007) PMID 17218594 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17035466&quot;&amp;gt;Documenting research in scientific articles: guidelines for authors: reporting research designs and activities. Chest 130(4):1263-8 (2006) PMID 17035466 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID11948065&quot;&amp;gt;The design of randomized clinical trials in critically ill patients. Chest 121(4):1290-300 (2002) PMID 11948065 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID10988210&quot;&amp;gt;Reality and meta-analyses. Chest 118(3):835-6 (2000) PMID 10988210 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID10988209&quot;&amp;gt;Is meta-analysis a metaphysical or a scientific method? Chest 118(3):832-4 (2000) PMID 10988209 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID10453885&quot;&amp;gt;Is meta-analysis really meta-physics? Chest 116(2):539-42 (1999) PMID 10453885 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID12386142&quot;&amp;gt;Advice on statistical analysis for Circulation Research. Circ Res 91(8):662-71 (2002) PMID 12386142 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18981315&quot;&amp;gt;A primer in longitudinal data analysis. Circulation 118(19):2005-10 (2008) PMID 18981315 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18711024&quot;&amp;gt;Some old and some new statistical tools for outcomes research. Circulation 118(8):872-84 (2008) PMID 18711024 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18519862&quot;&amp;gt;Survival methods: additional topics. Circulation 117(22):2949-55 (2008) PMID 18519862 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18506018&quot;&amp;gt;Methods and limitations of assessing new noninvasive tests: Part II: Outcomes-based validation and reliability assessment of noninvasive testing. Circulation 117(21):2793-801 (2008) PMID 18506018 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18490536&quot;&amp;gt;Methods and limitations of assessing new noninvasive tests: part I: Anatomy-based validation of noninvasive testing. Circulation 117(20):2684-90 (2008) PMID 18490536 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18458181&quot;&amp;gt;Logistic regression. Circulation 117(18):2395-9 (2008) PMID 18458181 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18378626&quot;&amp;gt;Multiple linear regression: accounting for multiple simultaneous determinants of a continuous dependent variable. Circulation 117(13):1732-7 (2008) PMID 18378626 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18172051&quot;&amp;gt;Analysis of variance. Circulation 117(1):115-21 (2008) PMID 18172051 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17965399&quot;&amp;gt;Association studies in an era of too much information: clinical analysis of new biomarker and genetic data. Circulation 116(17):1866-70 (2007) PMID 17965399 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17893285&quot;&amp;gt;What exactly do the trends mean? Circulation 116(13):1437-9 (2007) PMID 17893285 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17548743&quot;&amp;gt;Meta-analysis. Circulation 115(22):2870-5 (2007) PMID 17548743 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17404173&quot;&amp;gt;Evaluation of randomized controlled trials. Circulation 115(13):1819-22 (2007) PMID 17404173 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17339574&quot;&amp;gt;Design of randomized controlled trials. Circulation 115(9):1164-9 (2007) PMID 17339574 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17309939&quot;&amp;gt;Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115(7):928-35 (2007) PMID 17309939 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17283280&quot;&amp;gt;Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation 115(5):654-7 (2007) PMID 17283280 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17200454&quot;&amp;gt;Survival methods. Circulation 115(1):109-13 (2007) PMID 17200454 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID16365198&quot;&amp;gt;Standards for statistical models used for public reporting of health outcomes: an American Heart Association Scientific Statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group: cosponsored by the Council on Epidemiology and Prevention and the Stroke Council. Endorsed by the American College of Cardiology Foundation. Circulation 113(3):456-62 (2006) PMID 16365198 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID15173053&quot;&amp;gt;The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis. Circulation 109(21):e305-7 (2004) PMID 15173053 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID15173052&quot;&amp;gt;The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design. Circulation 109(21):e302-4 (2004) PMID 15173052 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18728215&quot;&amp;gt;Interpreting results of clinical trials: a conceptual framework. Clin J Am Soc Nephrol 3(5):1246-52 (2008) PMID 18728215 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18178786&quot;&amp;gt;Systematic review and meta-analysis: when one study is just not enough. Clin J Am Soc Nephrol 3(1):253-60 (2008) PMID 18178786 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17699379&quot;&amp;gt;Practice recommendations based on low, very low, and missing evidence. Clin J Am Soc Nephrol 2(1):11-2 (2007) PMID 17699379 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17699334&quot;&amp;gt;Cohort studies: marching forward. Clin J Am Soc Nephrol 1(5):1117-23 (2006) PMID 17699334 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17107979&quot;&amp;gt;The meta-analysis: supportive or illuminating? Eur Heart J 27(23):2744-5 (2006) PMID 17107979 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID16870690&quot;&amp;gt;Progress and problems for randomized clinical trials: from streptomycin to the era of megatrials. Eur Heart J 27(18):2158-64 (2006) PMID 16870690 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID16785246&quot;&amp;gt;Limitations of analyses of effectiveness using observational data. Eur Heart J 27(14):1642-3 (2006) PMID 16785246 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID15253985&quot;&amp;gt;Interpretation of observational studies. Heart 90(8):956-60 (2004) PMID 15253985 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID11302989&quot;&amp;gt;Absolute, attributable, and relative risk in the management of coronary heart disease. Heart 85(5):491-2 (2001) PMID 11302989 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID15985692&quot;&amp;gt;Statistical issues in the analysis of neuronal data. J Neurophysiol 94(1):8-25 (2005) PMID 15985692 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18097119&quot;&amp;gt;The Bayesian clinician. J Postgrad Med 53(4):267-9 (2007) PMID 18097119 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID7996506&quot;&amp;gt;Statistics in medical research--III. Correlation and regression analysis. J Postgrad Med 39(4):235-43 (1993) PMID 7996506 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17652297&quot;&amp;gt;Data extraction errors in meta-analyses that use standardized mean differences. JAMA 298(4):430-7 (2007) PMID 17652297 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID12038922&quot;&amp;gt;How statistical expertise is used in medical research. JAMA 287(21):2817-20 (2002) PMID 12038922 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID11497536&quot;&amp;gt;Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 286(7):821-30 (2001) PMID 11497536 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID9676681&quot;&amp;gt;Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals. JAMA 280(3):278-80 (1998) PMID 9676681 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID9551387&quot;&amp;gt;Meta-analysis as a clinical tool in nephrology. Kidney Int 53(4):819-25 (1998) PMID 9551387 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18182407&quot;&amp;gt;Clinical research of kidney diseases IV: Standard regression models. Nephrol Dial Transplant 23(2):475-82 (2008) PMID 18182407 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17332213&quot;&amp;gt;P less than .05: what does it really mean? Pediatrics 119(3):608-10 (2007) PMID 17332213 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID11884693&quot;&amp;gt;Data and models determine treatment proposals--an illustration from meta-analysis. Postgrad Med J 78(917):131-4 (2002) PMID 11884693 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID11222834&quot;&amp;gt;Balancing statistical and clinical significance in evaluating treatment effects. Postgrad Med J 77(905):201-4 (2001) PMID 11222834 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID10211346&quot;&amp;gt;Statistics in medicine: some considerations from a clinician&#039;s point of view. Postgrad Med J 74(876):577-8 (1998) PMID 10211346 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID10662865&quot;&amp;gt;Potential bias in Kaplan-Meier survival analysis applied to rheumatology drug studies. Rheumatology (Oxford) 39(1):1-2 (2000) PMID 10662865 &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID16059787&quot;&amp;gt;When should you use statistics? Swiss Med Wkly 135(23-24):337-8 (2005) PMID 16059787 &lt;/del&gt;&amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID14655052&quot;&amp;gt;Statistics in medical research. Swiss Med Wkly 133(39-40):522-9 (2003) PMID 14655052 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID14655051&quot;&amp;gt;Statistics in medicine. Swiss Med Wkly 133(39-40):521 (2003) PMID 14655051 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID1877042&quot;&amp;gt;Statistics in respiratory medicine. 3. Scale, parametric methods, and transformations. Thorax 46(7):536-8 (1991) PMID 1877042 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID1858087&quot;&amp;gt;Statistics in respiratory medicine. 2. Repeatability and method comparison. Thorax 46(6):454-6 (1991) PMID 1858087 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID15483190&quot;&amp;gt;A statistical evaluation of toxicity study designs for the estimation of the benchmark dose in continuous endpoints. Toxicol Sci 84(1):167-85 (2005) PMID 15483190 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID11353128&quot;&amp;gt;Statistical issues in the analysis of low-dose endocrine disruptor data. Toxicol Sci 61(2):201-10 (2001) PMID 11353128 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17058242&quot;&amp;gt;Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies. Hepatology 44(5):1075-82 (2006) PMID 17058242 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID8666350&quot;&amp;gt;Meta-analysis: an introduction and point of view. Hepatology 23(4):917-28 (1996) PMID 8666350 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18617074&quot;&amp;gt;Meta-analysis. J Am Coll Cardiol 52(3):237-8 (2008) PMID 18617074 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID15172393&quot;&amp;gt;Prior convictions: Bayesian approaches to the analysis and interpretation of clinical megatrials. J Am Coll Cardiol 43(11):1929-39 (2004) PMID 15172393 &amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;ref name=&quot;PMID18755930&quot;&amp;gt;When is a negative phase II trial truly negative? Am J Respir Crit Care Med 178(6):554-5 (2008) PMID 18755930 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID15590885&quot;&amp;gt;The ethical conduct of clinical research involving critically ill patients in the United States and Canada: principles and recommendations. Am J Respir Crit Care Med 170(12):1375-84 (2004) PMID 15590885 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID15151921&quot;&amp;gt;Positive clinical trials: understand the control group before implementing the result. Am J Respir Crit Care Med 170(3):223-6 (2004) PMID 15151921 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID9424990&quot;&amp;gt;Number needed to treat and relative risk reduction. Ann Intern Med 128(1):72-3 (1998) PMID 9424990 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID7486471&quot;&amp;gt;Discordance between meta-analyses and large-scale randomized, controlled trials. Examples from the management of acute myocardial infarction. Ann Intern Med 123(11):873-7 (1995) PMID 7486471 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID16040886&quot;&amp;gt;Understanding systematic reviews and meta-analysis. Arch Dis Child 90(8):845-8 (2005) PMID 16040886 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID15102650&quot;&amp;gt;GRADE: levels of evidence and grades of recommendation. Arch Dis Child 89(5):489 (2004) PMID 15102650 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID7492177&quot;&amp;gt;Statistics from the inside. 16. Multiple regression (2). Arch Dis Child 73(3):270-4 (1995) PMID 7492177 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID8067802&quot;&amp;gt;Statistics from the inside. 13. Probability and decisions. Arch Dis Child 71(1):90-4 (1994) PMID 8067802 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID8333779&quot;&amp;gt;10. Counted data (2). Arch Dis Child 68(6):800-2 (1993) PMID 8333779 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID8481051&quot;&amp;gt;Counted data (1). Arch Dis Child 68(2):246-9 (1993) PMID 8481051 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID1444537&quot;&amp;gt;Statistics from the inside. 7. Regression and correlation. Arch Dis Child 67(10):1306-9 (1992) PMID 1444537 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID1626999&quot;&amp;gt;Statistics from the inside. 6. Data structures (continued). Arch Dis Child 67(6):757-9 (1992) PMID 1626999 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17296672&quot;&amp;gt;Documenting research in scientific articles: Guidelines for authors: 3. Reporting multivariate analyses. Chest 131(2):628-32 (2007) PMID 17296672 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17218594&quot;&amp;gt;Documenting research in scientific articles: guidelines for authors: 2. Reporting hypothesis tests. Chest 131(1):317-9 (2007) PMID 17218594 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17035466&quot;&amp;gt;Documenting research in scientific articles: guidelines for authors: reporting research designs and activities. Chest 130(4):1263-8 (2006) PMID 17035466 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID11948065&quot;&amp;gt;The design of randomized clinical trials in critically ill patients. Chest 121(4):1290-300 (2002) PMID 11948065 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID10988210&quot;&amp;gt;Reality and meta-analyses. Chest 118(3):835-6 (2000) PMID 10988210 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID10988209&quot;&amp;gt;Is meta-analysis a metaphysical or a scientific method? Chest 118(3):832-4 (2000) PMID 10988209 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID10453885&quot;&amp;gt;Is meta-analysis really meta-physics? Chest 116(2):539-42 (1999) PMID 10453885 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID12386142&quot;&amp;gt;Advice on statistical analysis for Circulation Research. Circ Res 91(8):662-71 (2002) PMID 12386142 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18981315&quot;&amp;gt;A primer in longitudinal data analysis. Circulation 118(19):2005-10 (2008) PMID 18981315 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18711024&quot;&amp;gt;Some old and some new statistical tools for outcomes research. Circulation 118(8):872-84 (2008) PMID 18711024 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18519862&quot;&amp;gt;Survival methods: additional topics. Circulation 117(22):2949-55 (2008) PMID 18519862 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18506018&quot;&amp;gt;Methods and limitations of assessing new noninvasive tests: Part II: Outcomes-based validation and reliability assessment of noninvasive testing. Circulation 117(21):2793-801 (2008) PMID 18506018 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18490536&quot;&amp;gt;Methods and limitations of assessing new noninvasive tests: part I: Anatomy-based validation of noninvasive testing. Circulation 117(20):2684-90 (2008) PMID 18490536 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18458181&quot;&amp;gt;Logistic regression. Circulation 117(18):2395-9 (2008) PMID 18458181 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18378626&quot;&amp;gt;Multiple linear regression: accounting for multiple simultaneous determinants of a continuous dependent variable. Circulation 117(13):1732-7 (2008) PMID 18378626 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18172051&quot;&amp;gt;Analysis of variance. Circulation 117(1):115-21 (2008) PMID 18172051 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17965399&quot;&amp;gt;Association studies in an era of too much information: clinical analysis of new biomarker and genetic data. Circulation 116(17):1866-70 (2007) PMID 17965399 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17893285&quot;&amp;gt;What exactly do the trends mean? Circulation 116(13):1437-9 (2007) PMID 17893285 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17548743&quot;&amp;gt;Meta-analysis. Circulation 115(22):2870-5 (2007) PMID 17548743 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17404173&quot;&amp;gt;Evaluation of randomized controlled trials. Circulation 115(13):1819-22 (2007) PMID 17404173 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17339574&quot;&amp;gt;Design of randomized controlled trials. Circulation 115(9):1164-9 (2007) PMID 17339574 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17309939&quot;&amp;gt;Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115(7):928-35 (2007) PMID 17309939 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17283280&quot;&amp;gt;Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation 115(5):654-7 (2007) PMID 17283280 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17200454&quot;&amp;gt;Survival methods. Circulation 115(1):109-13 (2007) PMID 17200454 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID16365198&quot;&amp;gt;Standards for statistical models used for public reporting of health outcomes: an American Heart Association Scientific Statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group: cosponsored by the Council on Epidemiology and Prevention and the Stroke Council. Endorsed by the American College of Cardiology Foundation. Circulation 113(3):456-62 (2006) PMID 16365198 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID15173053&quot;&amp;gt;The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis. Circulation 109(21):e305-7 (2004) PMID 15173053 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID15173052&quot;&amp;gt;The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design. Circulation 109(21):e302-4 (2004) PMID 15173052 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18728215&quot;&amp;gt;Interpreting results of clinical trials: a conceptual framework. Clin J Am Soc Nephrol 3(5):1246-52 (2008) PMID 18728215 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18178786&quot;&amp;gt;Systematic review and meta-analysis: when one study is just not enough. Clin J Am Soc Nephrol 3(1):253-60 (2008) PMID 18178786 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17699379&quot;&amp;gt;Practice recommendations based on low, very low, and missing evidence. Clin J Am Soc Nephrol 2(1):11-2 (2007) PMID 17699379 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17699334&quot;&amp;gt;Cohort studies: marching forward. Clin J Am Soc Nephrol 1(5):1117-23 (2006) PMID 17699334 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17107979&quot;&amp;gt;The meta-analysis: supportive or illuminating? Eur Heart J 27(23):2744-5 (2006) PMID 17107979 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID16870690&quot;&amp;gt;Progress and problems for randomized clinical trials: from streptomycin to the era of megatrials. Eur Heart J 27(18):2158-64 (2006) PMID 16870690 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID16785246&quot;&amp;gt;Limitations of analyses of effectiveness using observational data. Eur Heart J 27(14):1642-3 (2006) PMID 16785246 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID15253985&quot;&amp;gt;Interpretation of observational studies. Heart 90(8):956-60 (2004) PMID 15253985 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID11302989&quot;&amp;gt;Absolute, attributable, and relative risk in the management of coronary heart disease. Heart 85(5):491-2 (2001) PMID 11302989 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID15985692&quot;&amp;gt;Statistical issues in the analysis of neuronal data. J Neurophysiol 94(1):8-25 (2005) PMID 15985692 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18097119&quot;&amp;gt;The Bayesian clinician. J Postgrad Med 53(4):267-9 (2007) PMID 18097119 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID7996506&quot;&amp;gt;Statistics in medical research--III. Correlation and regression analysis. J Postgrad Med 39(4):235-43 (1993) PMID 7996506 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17652297&quot;&amp;gt;Data extraction errors in meta-analyses that use standardized mean differences. JAMA 298(4):430-7 (2007) PMID 17652297 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID12038922&quot;&amp;gt;How statistical expertise is used in medical research. JAMA 287(21):2817-20 (2002) PMID 12038922 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID11497536&quot;&amp;gt;Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 286(7):821-30 (2001) PMID 11497536 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID9676681&quot;&amp;gt;Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals. JAMA 280(3):278-80 (1998) PMID 9676681 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID9551387&quot;&amp;gt;Meta-analysis as a clinical tool in nephrology. Kidney Int 53(4):819-25 (1998) PMID 9551387 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18182407&quot;&amp;gt;Clinical research of kidney diseases IV: Standard regression models. Nephrol Dial Transplant 23(2):475-82 (2008) PMID 18182407 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17332213&quot;&amp;gt;P less than .05: what does it really mean? Pediatrics 119(3):608-10 (2007) PMID 17332213 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID11884693&quot;&amp;gt;Data and models determine treatment proposals--an illustration from meta-analysis. Postgrad Med J 78(917):131-4 (2002) PMID 11884693 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID11222834&quot;&amp;gt;Balancing statistical and clinical significance in evaluating treatment effects. Postgrad Med J 77(905):201-4 (2001) PMID 11222834 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID10211346&quot;&amp;gt;Statistics in medicine: some considerations from a clinician&#039;s point of view. Postgrad Med J 74(876):577-8 (1998) PMID 10211346 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID10662865&quot;&amp;gt;Potential bias in Kaplan-Meier survival analysis applied to rheumatology drug studies. Rheumatology (Oxford) 39(1):1-2 (2000) PMID 10662865 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID14655052&quot;&amp;gt;Statistics in medical research. Swiss Med Wkly 133(39-40):522-9 (2003) PMID 14655052 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID14655051&quot;&amp;gt;Statistics in medicine. Swiss Med Wkly 133(39-40):521 (2003) PMID 14655051 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID1877042&quot;&amp;gt;Statistics in respiratory medicine. 3. Scale, parametric methods, and transformations. Thorax 46(7):536-8 (1991) PMID 1877042 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID1858087&quot;&amp;gt;Statistics in respiratory medicine. 2. Repeatability and method comparison. Thorax 46(6):454-6 (1991) PMID 1858087 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID15483190&quot;&amp;gt;A statistical evaluation of toxicity study designs for the estimation of the benchmark dose in continuous endpoints. Toxicol Sci 84(1):167-85 (2005) PMID 15483190 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID11353128&quot;&amp;gt;Statistical issues in the analysis of low-dose endocrine disruptor data. Toxicol Sci 61(2):201-10 (2001) PMID 11353128 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID17058242&quot;&amp;gt;Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies. Hepatology 44(5):1075-82 (2006) PMID 17058242 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID8666350&quot;&amp;gt;Meta-analysis: an introduction and point of view. Hepatology 23(4):917-28 (1996) PMID 8666350 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18617074&quot;&amp;gt;Meta-analysis. J Am Coll Cardiol 52(3):237-8 (2008) PMID 18617074 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID15172393&quot;&amp;gt;Prior convictions: Bayesian approaches to the analysis and interpretation of clinical megatrials. J Am Coll Cardiol 43(11):1929-39 (2004) PMID 15172393 &amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Bibliographie ==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Bibliographie ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;references /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;references /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Fmrauch</name></author>
	</entry>
	<entry>
		<id>https://h.suprapedia.de/w/index.php?title=Statistik_und_Studiendesign&amp;diff=958401&amp;oldid=prev</id>
		<title>Fmrauch: sinnvolle Kat.</title>
		<link rel="alternate" type="text/html" href="https://h.suprapedia.de/w/index.php?title=Statistik_und_Studiendesign&amp;diff=958401&amp;oldid=prev"/>
		<updated>2024-11-19T18:48:00Z</updated>

		<summary type="html">&lt;p&gt;sinnvolle Kat.&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;de&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Nächstältere Version&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Version vom 19. November 2024, 18:48 Uhr&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l5&quot;&gt;Zeile 5:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Zeile 5:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;references /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;references /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;{{PPA-Zirkon}}&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;{{PPA-Zirkon}}&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[Kategorie:Methodologie]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Fmrauch</name></author>
	</entry>
	<entry>
		<id>https://h.suprapedia.de/w/index.php?title=Statistik_und_Studiendesign&amp;diff=958398&amp;oldid=prev</id>
		<title>Fmrauch: zuviele und willkürliche Quellen</title>
		<link rel="alternate" type="text/html" href="https://h.suprapedia.de/w/index.php?title=Statistik_und_Studiendesign&amp;diff=958398&amp;oldid=prev"/>
		<updated>2024-11-19T18:45:45Z</updated>

		<summary type="html">&lt;p&gt;zuviele und willkürliche Quellen&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;de&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Nächstältere Version&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Version vom 19. November 2024, 18:45 Uhr&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Zeile 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Zeile 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Statistik&amp;#039;&amp;#039;&amp;#039; und &amp;#039;&amp;#039;&amp;#039;Studiendesign&amp;#039;&amp;#039;&amp;#039; sind wesentliche Grundlagen in vielen Bereichen wissenschaftlicher Forschung. Die gilt insbesondere in den [[Naturwissenschaft]]en.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Statistik&amp;#039;&amp;#039;&amp;#039; und &amp;#039;&amp;#039;&amp;#039;Studiendesign&amp;#039;&amp;#039;&amp;#039; sind wesentliche Grundlagen in vielen Bereichen wissenschaftlicher Forschung. Die gilt insbesondere in den [[Naturwissenschaft]]en.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;{| class=&quot;wikitable&quot; |&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Freie Übersichtsartikel &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;...&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;| bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Siehe auch&#039;&#039;&#039;&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;| align=&quot;left&quot; width=&quot;800&quot; |&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;|-&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;| bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;&lt;/del&gt;Freie Übersichtsartikel&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&#039;&#039;&#039;&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;| align=&quot;left&quot; width=&quot;800&quot; |&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;ref name=&amp;quot;PMID18755930&amp;quot;&amp;gt;When is a negative phase II trial truly negative? Am J Respir Crit Care Med 178(6):554-5 (2008) PMID 18755930 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15590885&amp;quot;&amp;gt;The ethical conduct of clinical research involving critically ill patients in the United States and Canada: principles and recommendations. Am J Respir Crit Care Med 170(12):1375-84 (2004) PMID 15590885 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15151921&amp;quot;&amp;gt;Positive clinical trials: understand the control group before implementing the result. Am J Respir Crit Care Med 170(3):223-6 (2004) PMID 15151921 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID9424990&amp;quot;&amp;gt;Number needed to treat and relative risk reduction. Ann Intern Med 128(1):72-3 (1998) PMID 9424990 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID7486471&amp;quot;&amp;gt;Discordance between meta-analyses and large-scale randomized, controlled trials. Examples from the management of acute myocardial infarction. Ann Intern Med 123(11):873-7 (1995) PMID 7486471 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID16040886&amp;quot;&amp;gt;Understanding systematic reviews and meta-analysis. Arch Dis Child 90(8):845-8 (2005) PMID 16040886 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15102650&amp;quot;&amp;gt;GRADE: levels of evidence and grades of recommendation. Arch Dis Child 89(5):489 (2004) PMID 15102650 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID7492177&amp;quot;&amp;gt;Statistics from the inside. 16. Multiple regression (2). Arch Dis Child 73(3):270-4 (1995) PMID 7492177 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID8067802&amp;quot;&amp;gt;Statistics from the inside. 13. Probability and decisions. Arch Dis Child 71(1):90-4 (1994) PMID 8067802 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID8333779&amp;quot;&amp;gt;10. Counted data (2). Arch Dis Child 68(6):800-2 (1993) PMID 8333779 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID8481051&amp;quot;&amp;gt;Counted data (1). Arch Dis Child 68(2):246-9 (1993) PMID 8481051 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID1444537&amp;quot;&amp;gt;Statistics from the inside. 7. Regression and correlation. Arch Dis Child 67(10):1306-9 (1992) PMID 1444537 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID1626999&amp;quot;&amp;gt;Statistics from the inside. 6. Data structures (continued). Arch Dis Child 67(6):757-9 (1992) PMID 1626999 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17296672&amp;quot;&amp;gt;Documenting research in scientific articles: Guidelines for authors: 3. Reporting multivariate analyses. Chest 131(2):628-32 (2007) PMID 17296672 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17218594&amp;quot;&amp;gt;Documenting research in scientific articles: guidelines for authors: 2. Reporting hypothesis tests. Chest 131(1):317-9 (2007) PMID 17218594 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17035466&amp;quot;&amp;gt;Documenting research in scientific articles: guidelines for authors: reporting research designs and activities. Chest 130(4):1263-8 (2006) PMID 17035466 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID11948065&amp;quot;&amp;gt;The design of randomized clinical trials in critically ill patients. Chest 121(4):1290-300 (2002) PMID 11948065 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID10988210&amp;quot;&amp;gt;Reality and meta-analyses. Chest 118(3):835-6 (2000) PMID 10988210 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID10988209&amp;quot;&amp;gt;Is meta-analysis a metaphysical or a scientific method? Chest 118(3):832-4 (2000) PMID 10988209 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID10453885&amp;quot;&amp;gt;Is meta-analysis really meta-physics? Chest 116(2):539-42 (1999) PMID 10453885 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID12386142&amp;quot;&amp;gt;Advice on statistical analysis for Circulation Research. Circ Res 91(8):662-71 (2002) PMID 12386142 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18981315&amp;quot;&amp;gt;A primer in longitudinal data analysis. Circulation 118(19):2005-10 (2008) PMID 18981315 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18711024&amp;quot;&amp;gt;Some old and some new statistical tools for outcomes research. Circulation 118(8):872-84 (2008) PMID 18711024 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18519862&amp;quot;&amp;gt;Survival methods: additional topics. Circulation 117(22):2949-55 (2008) PMID 18519862 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18506018&amp;quot;&amp;gt;Methods and limitations of assessing new noninvasive tests: Part II: Outcomes-based validation and reliability assessment of noninvasive testing. Circulation 117(21):2793-801 (2008) PMID 18506018 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18490536&amp;quot;&amp;gt;Methods and limitations of assessing new noninvasive tests: part I: Anatomy-based validation of noninvasive testing. Circulation 117(20):2684-90 (2008) PMID 18490536 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18458181&amp;quot;&amp;gt;Logistic regression. Circulation 117(18):2395-9 (2008) PMID 18458181 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18378626&amp;quot;&amp;gt;Multiple linear regression: accounting for multiple simultaneous determinants of a continuous dependent variable. Circulation 117(13):1732-7 (2008) PMID 18378626 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18172051&amp;quot;&amp;gt;Analysis of variance. Circulation 117(1):115-21 (2008) PMID 18172051 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17965399&amp;quot;&amp;gt;Association studies in an era of too much information: clinical analysis of new biomarker and genetic data. Circulation 116(17):1866-70 (2007) PMID 17965399 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17893285&amp;quot;&amp;gt;What exactly do the trends mean? Circulation 116(13):1437-9 (2007) PMID 17893285 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17548743&amp;quot;&amp;gt;Meta-analysis. Circulation 115(22):2870-5 (2007) PMID 17548743 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17404173&amp;quot;&amp;gt;Evaluation of randomized controlled trials. Circulation 115(13):1819-22 (2007) PMID 17404173 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17339574&amp;quot;&amp;gt;Design of randomized controlled trials. Circulation 115(9):1164-9 (2007) PMID 17339574 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17309939&amp;quot;&amp;gt;Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115(7):928-35 (2007) PMID 17309939 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17283280&amp;quot;&amp;gt;Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation 115(5):654-7 (2007) PMID 17283280 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17200454&amp;quot;&amp;gt;Survival methods. Circulation 115(1):109-13 (2007) PMID 17200454 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID16365198&amp;quot;&amp;gt;Standards for statistical models used for public reporting of health outcomes: an American Heart Association Scientific Statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group: cosponsored by the Council on Epidemiology and Prevention and the Stroke Council. Endorsed by the American College of Cardiology Foundation. Circulation 113(3):456-62 (2006) PMID 16365198 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15173053&amp;quot;&amp;gt;The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis. Circulation 109(21):e305-7 (2004) PMID 15173053 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15173052&amp;quot;&amp;gt;The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design. Circulation 109(21):e302-4 (2004) PMID 15173052 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18728215&amp;quot;&amp;gt;Interpreting results of clinical trials: a conceptual framework. Clin J Am Soc Nephrol 3(5):1246-52 (2008) PMID 18728215 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18178786&amp;quot;&amp;gt;Systematic review and meta-analysis: when one study is just not enough. Clin J Am Soc Nephrol 3(1):253-60 (2008) PMID 18178786 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17699379&amp;quot;&amp;gt;Practice recommendations based on low, very low, and missing evidence. Clin J Am Soc Nephrol 2(1):11-2 (2007) PMID 17699379 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17699334&amp;quot;&amp;gt;Cohort studies: marching forward. Clin J Am Soc Nephrol 1(5):1117-23 (2006) PMID 17699334 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17107979&amp;quot;&amp;gt;The meta-analysis: supportive or illuminating? Eur Heart J 27(23):2744-5 (2006) PMID 17107979 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID16870690&amp;quot;&amp;gt;Progress and problems for randomized clinical trials: from streptomycin to the era of megatrials. Eur Heart J 27(18):2158-64 (2006) PMID 16870690 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID16785246&amp;quot;&amp;gt;Limitations of analyses of effectiveness using observational data. Eur Heart J 27(14):1642-3 (2006) PMID 16785246 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15253985&amp;quot;&amp;gt;Interpretation of observational studies. Heart 90(8):956-60 (2004) PMID 15253985 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID11302989&amp;quot;&amp;gt;Absolute, attributable, and relative risk in the management of coronary heart disease. Heart 85(5):491-2 (2001) PMID 11302989 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15985692&amp;quot;&amp;gt;Statistical issues in the analysis of neuronal data. J Neurophysiol 94(1):8-25 (2005) PMID 15985692 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18097119&amp;quot;&amp;gt;The Bayesian clinician. J Postgrad Med 53(4):267-9 (2007) PMID 18097119 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID7996506&amp;quot;&amp;gt;Statistics in medical research--III. Correlation and regression analysis. J Postgrad Med 39(4):235-43 (1993) PMID 7996506 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17652297&amp;quot;&amp;gt;Data extraction errors in meta-analyses that use standardized mean differences. JAMA 298(4):430-7 (2007) PMID 17652297 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID12038922&amp;quot;&amp;gt;How statistical expertise is used in medical research. JAMA 287(21):2817-20 (2002) PMID 12038922 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID11497536&amp;quot;&amp;gt;Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 286(7):821-30 (2001) PMID 11497536 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID9676681&amp;quot;&amp;gt;Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals. JAMA 280(3):278-80 (1998) PMID 9676681 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID9551387&amp;quot;&amp;gt;Meta-analysis as a clinical tool in nephrology. Kidney Int 53(4):819-25 (1998) PMID 9551387 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18182407&amp;quot;&amp;gt;Clinical research of kidney diseases IV: Standard regression models. Nephrol Dial Transplant 23(2):475-82 (2008) PMID 18182407 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17332213&amp;quot;&amp;gt;P less than .05: what does it really mean? Pediatrics 119(3):608-10 (2007) PMID 17332213 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID11884693&amp;quot;&amp;gt;Data and models determine treatment proposals--an illustration from meta-analysis. Postgrad Med J 78(917):131-4 (2002) PMID 11884693 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID11222834&amp;quot;&amp;gt;Balancing statistical and clinical significance in evaluating treatment effects. Postgrad Med J 77(905):201-4 (2001) PMID 11222834 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID10211346&amp;quot;&amp;gt;Statistics in medicine: some considerations from a clinician&amp;#039;s point of view. Postgrad Med J 74(876):577-8 (1998) PMID 10211346 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID10662865&amp;quot;&amp;gt;Potential bias in Kaplan-Meier survival analysis applied to rheumatology drug studies. Rheumatology (Oxford) 39(1):1-2 (2000) PMID 10662865 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID16059787&amp;quot;&amp;gt;When should you use statistics? Swiss Med Wkly 135(23-24):337-8 (2005) PMID 16059787 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID14655052&amp;quot;&amp;gt;Statistics in medical research. Swiss Med Wkly 133(39-40):522-9 (2003) PMID 14655052 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID14655051&amp;quot;&amp;gt;Statistics in medicine. Swiss Med Wkly 133(39-40):521 (2003) PMID 14655051 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID1877042&amp;quot;&amp;gt;Statistics in respiratory medicine. 3. Scale, parametric methods, and transformations. Thorax 46(7):536-8 (1991) PMID 1877042 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID1858087&amp;quot;&amp;gt;Statistics in respiratory medicine. 2. Repeatability and method comparison. Thorax 46(6):454-6 (1991) PMID 1858087 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15483190&amp;quot;&amp;gt;A statistical evaluation of toxicity study designs for the estimation of the benchmark dose in continuous endpoints. Toxicol Sci 84(1):167-85 (2005) PMID 15483190 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID11353128&amp;quot;&amp;gt;Statistical issues in the analysis of low-dose endocrine disruptor data. Toxicol Sci 61(2):201-10 (2001) PMID 11353128 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17058242&amp;quot;&amp;gt;Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies. Hepatology 44(5):1075-82 (2006) PMID 17058242 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID8666350&amp;quot;&amp;gt;Meta-analysis: an introduction and point of view. Hepatology 23(4):917-28 (1996) PMID 8666350 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18617074&amp;quot;&amp;gt;Meta-analysis. J Am Coll Cardiol 52(3):237-8 (2008) PMID 18617074 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15172393&amp;quot;&amp;gt;Prior convictions: Bayesian approaches to the analysis and interpretation of clinical megatrials. J Am Coll Cardiol 43(11):1929-39 (2004) PMID 15172393 &amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;ref name=&amp;quot;PMID18755930&amp;quot;&amp;gt;When is a negative phase II trial truly negative? Am J Respir Crit Care Med 178(6):554-5 (2008) PMID 18755930 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15590885&amp;quot;&amp;gt;The ethical conduct of clinical research involving critically ill patients in the United States and Canada: principles and recommendations. Am J Respir Crit Care Med 170(12):1375-84 (2004) PMID 15590885 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15151921&amp;quot;&amp;gt;Positive clinical trials: understand the control group before implementing the result. Am J Respir Crit Care Med 170(3):223-6 (2004) PMID 15151921 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID9424990&amp;quot;&amp;gt;Number needed to treat and relative risk reduction. Ann Intern Med 128(1):72-3 (1998) PMID 9424990 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID7486471&amp;quot;&amp;gt;Discordance between meta-analyses and large-scale randomized, controlled trials. Examples from the management of acute myocardial infarction. Ann Intern Med 123(11):873-7 (1995) PMID 7486471 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID16040886&amp;quot;&amp;gt;Understanding systematic reviews and meta-analysis. Arch Dis Child 90(8):845-8 (2005) PMID 16040886 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15102650&amp;quot;&amp;gt;GRADE: levels of evidence and grades of recommendation. Arch Dis Child 89(5):489 (2004) PMID 15102650 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID7492177&amp;quot;&amp;gt;Statistics from the inside. 16. Multiple regression (2). Arch Dis Child 73(3):270-4 (1995) PMID 7492177 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID8067802&amp;quot;&amp;gt;Statistics from the inside. 13. Probability and decisions. Arch Dis Child 71(1):90-4 (1994) PMID 8067802 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID8333779&amp;quot;&amp;gt;10. Counted data (2). Arch Dis Child 68(6):800-2 (1993) PMID 8333779 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID8481051&amp;quot;&amp;gt;Counted data (1). Arch Dis Child 68(2):246-9 (1993) PMID 8481051 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID1444537&amp;quot;&amp;gt;Statistics from the inside. 7. Regression and correlation. Arch Dis Child 67(10):1306-9 (1992) PMID 1444537 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID1626999&amp;quot;&amp;gt;Statistics from the inside. 6. Data structures (continued). Arch Dis Child 67(6):757-9 (1992) PMID 1626999 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17296672&amp;quot;&amp;gt;Documenting research in scientific articles: Guidelines for authors: 3. Reporting multivariate analyses. Chest 131(2):628-32 (2007) PMID 17296672 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17218594&amp;quot;&amp;gt;Documenting research in scientific articles: guidelines for authors: 2. Reporting hypothesis tests. Chest 131(1):317-9 (2007) PMID 17218594 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17035466&amp;quot;&amp;gt;Documenting research in scientific articles: guidelines for authors: reporting research designs and activities. Chest 130(4):1263-8 (2006) PMID 17035466 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID11948065&amp;quot;&amp;gt;The design of randomized clinical trials in critically ill patients. Chest 121(4):1290-300 (2002) PMID 11948065 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID10988210&amp;quot;&amp;gt;Reality and meta-analyses. Chest 118(3):835-6 (2000) PMID 10988210 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID10988209&amp;quot;&amp;gt;Is meta-analysis a metaphysical or a scientific method? Chest 118(3):832-4 (2000) PMID 10988209 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID10453885&amp;quot;&amp;gt;Is meta-analysis really meta-physics? Chest 116(2):539-42 (1999) PMID 10453885 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID12386142&amp;quot;&amp;gt;Advice on statistical analysis for Circulation Research. Circ Res 91(8):662-71 (2002) PMID 12386142 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18981315&amp;quot;&amp;gt;A primer in longitudinal data analysis. Circulation 118(19):2005-10 (2008) PMID 18981315 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18711024&amp;quot;&amp;gt;Some old and some new statistical tools for outcomes research. Circulation 118(8):872-84 (2008) PMID 18711024 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18519862&amp;quot;&amp;gt;Survival methods: additional topics. Circulation 117(22):2949-55 (2008) PMID 18519862 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18506018&amp;quot;&amp;gt;Methods and limitations of assessing new noninvasive tests: Part II: Outcomes-based validation and reliability assessment of noninvasive testing. Circulation 117(21):2793-801 (2008) PMID 18506018 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18490536&amp;quot;&amp;gt;Methods and limitations of assessing new noninvasive tests: part I: Anatomy-based validation of noninvasive testing. Circulation 117(20):2684-90 (2008) PMID 18490536 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18458181&amp;quot;&amp;gt;Logistic regression. Circulation 117(18):2395-9 (2008) PMID 18458181 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18378626&amp;quot;&amp;gt;Multiple linear regression: accounting for multiple simultaneous determinants of a continuous dependent variable. Circulation 117(13):1732-7 (2008) PMID 18378626 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18172051&amp;quot;&amp;gt;Analysis of variance. Circulation 117(1):115-21 (2008) PMID 18172051 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17965399&amp;quot;&amp;gt;Association studies in an era of too much information: clinical analysis of new biomarker and genetic data. Circulation 116(17):1866-70 (2007) PMID 17965399 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17893285&amp;quot;&amp;gt;What exactly do the trends mean? Circulation 116(13):1437-9 (2007) PMID 17893285 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17548743&amp;quot;&amp;gt;Meta-analysis. Circulation 115(22):2870-5 (2007) PMID 17548743 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17404173&amp;quot;&amp;gt;Evaluation of randomized controlled trials. Circulation 115(13):1819-22 (2007) PMID 17404173 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17339574&amp;quot;&amp;gt;Design of randomized controlled trials. Circulation 115(9):1164-9 (2007) PMID 17339574 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17309939&amp;quot;&amp;gt;Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115(7):928-35 (2007) PMID 17309939 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17283280&amp;quot;&amp;gt;Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation 115(5):654-7 (2007) PMID 17283280 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17200454&amp;quot;&amp;gt;Survival methods. Circulation 115(1):109-13 (2007) PMID 17200454 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID16365198&amp;quot;&amp;gt;Standards for statistical models used for public reporting of health outcomes: an American Heart Association Scientific Statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group: cosponsored by the Council on Epidemiology and Prevention and the Stroke Council. Endorsed by the American College of Cardiology Foundation. Circulation 113(3):456-62 (2006) PMID 16365198 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15173053&amp;quot;&amp;gt;The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis. Circulation 109(21):e305-7 (2004) PMID 15173053 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15173052&amp;quot;&amp;gt;The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design. Circulation 109(21):e302-4 (2004) PMID 15173052 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18728215&amp;quot;&amp;gt;Interpreting results of clinical trials: a conceptual framework. Clin J Am Soc Nephrol 3(5):1246-52 (2008) PMID 18728215 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18178786&amp;quot;&amp;gt;Systematic review and meta-analysis: when one study is just not enough. Clin J Am Soc Nephrol 3(1):253-60 (2008) PMID 18178786 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17699379&amp;quot;&amp;gt;Practice recommendations based on low, very low, and missing evidence. Clin J Am Soc Nephrol 2(1):11-2 (2007) PMID 17699379 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17699334&amp;quot;&amp;gt;Cohort studies: marching forward. Clin J Am Soc Nephrol 1(5):1117-23 (2006) PMID 17699334 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17107979&amp;quot;&amp;gt;The meta-analysis: supportive or illuminating? Eur Heart J 27(23):2744-5 (2006) PMID 17107979 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID16870690&amp;quot;&amp;gt;Progress and problems for randomized clinical trials: from streptomycin to the era of megatrials. Eur Heart J 27(18):2158-64 (2006) PMID 16870690 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID16785246&amp;quot;&amp;gt;Limitations of analyses of effectiveness using observational data. Eur Heart J 27(14):1642-3 (2006) PMID 16785246 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15253985&amp;quot;&amp;gt;Interpretation of observational studies. Heart 90(8):956-60 (2004) PMID 15253985 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID11302989&amp;quot;&amp;gt;Absolute, attributable, and relative risk in the management of coronary heart disease. Heart 85(5):491-2 (2001) PMID 11302989 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15985692&amp;quot;&amp;gt;Statistical issues in the analysis of neuronal data. J Neurophysiol 94(1):8-25 (2005) PMID 15985692 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18097119&amp;quot;&amp;gt;The Bayesian clinician. J Postgrad Med 53(4):267-9 (2007) PMID 18097119 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID7996506&amp;quot;&amp;gt;Statistics in medical research--III. Correlation and regression analysis. J Postgrad Med 39(4):235-43 (1993) PMID 7996506 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17652297&amp;quot;&amp;gt;Data extraction errors in meta-analyses that use standardized mean differences. JAMA 298(4):430-7 (2007) PMID 17652297 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID12038922&amp;quot;&amp;gt;How statistical expertise is used in medical research. JAMA 287(21):2817-20 (2002) PMID 12038922 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID11497536&amp;quot;&amp;gt;Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 286(7):821-30 (2001) PMID 11497536 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID9676681&amp;quot;&amp;gt;Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals. JAMA 280(3):278-80 (1998) PMID 9676681 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID9551387&amp;quot;&amp;gt;Meta-analysis as a clinical tool in nephrology. Kidney Int 53(4):819-25 (1998) PMID 9551387 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18182407&amp;quot;&amp;gt;Clinical research of kidney diseases IV: Standard regression models. Nephrol Dial Transplant 23(2):475-82 (2008) PMID 18182407 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17332213&amp;quot;&amp;gt;P less than .05: what does it really mean? Pediatrics 119(3):608-10 (2007) PMID 17332213 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID11884693&amp;quot;&amp;gt;Data and models determine treatment proposals--an illustration from meta-analysis. Postgrad Med J 78(917):131-4 (2002) PMID 11884693 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID11222834&amp;quot;&amp;gt;Balancing statistical and clinical significance in evaluating treatment effects. Postgrad Med J 77(905):201-4 (2001) PMID 11222834 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID10211346&amp;quot;&amp;gt;Statistics in medicine: some considerations from a clinician&amp;#039;s point of view. Postgrad Med J 74(876):577-8 (1998) PMID 10211346 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID10662865&amp;quot;&amp;gt;Potential bias in Kaplan-Meier survival analysis applied to rheumatology drug studies. Rheumatology (Oxford) 39(1):1-2 (2000) PMID 10662865 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID16059787&amp;quot;&amp;gt;When should you use statistics? Swiss Med Wkly 135(23-24):337-8 (2005) PMID 16059787 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID14655052&amp;quot;&amp;gt;Statistics in medical research. Swiss Med Wkly 133(39-40):522-9 (2003) PMID 14655052 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID14655051&amp;quot;&amp;gt;Statistics in medicine. Swiss Med Wkly 133(39-40):521 (2003) PMID 14655051 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID1877042&amp;quot;&amp;gt;Statistics in respiratory medicine. 3. Scale, parametric methods, and transformations. Thorax 46(7):536-8 (1991) PMID 1877042 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID1858087&amp;quot;&amp;gt;Statistics in respiratory medicine. 2. Repeatability and method comparison. Thorax 46(6):454-6 (1991) PMID 1858087 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15483190&amp;quot;&amp;gt;A statistical evaluation of toxicity study designs for the estimation of the benchmark dose in continuous endpoints. Toxicol Sci 84(1):167-85 (2005) PMID 15483190 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID11353128&amp;quot;&amp;gt;Statistical issues in the analysis of low-dose endocrine disruptor data. Toxicol Sci 61(2):201-10 (2001) PMID 11353128 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17058242&amp;quot;&amp;gt;Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies. Hepatology 44(5):1075-82 (2006) PMID 17058242 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID8666350&amp;quot;&amp;gt;Meta-analysis: an introduction and point of view. Hepatology 23(4):917-28 (1996) PMID 8666350 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18617074&amp;quot;&amp;gt;Meta-analysis. J Am Coll Cardiol 52(3):237-8 (2008) PMID 18617074 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15172393&amp;quot;&amp;gt;Prior convictions: Bayesian approaches to the analysis and interpretation of clinical megatrials. J Am Coll Cardiol 43(11):1929-39 (2004) PMID 15172393 &amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Bibliographie ==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Bibliographie ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Fmrauch</name></author>
	</entry>
	<entry>
		<id>https://h.suprapedia.de/w/index.php?title=Statistik_und_Studiendesign&amp;diff=958397&amp;oldid=prev</id>
		<title>Fmrauch: wieso hat das nur mit Medizin zu tun?</title>
		<link rel="alternate" type="text/html" href="https://h.suprapedia.de/w/index.php?title=Statistik_und_Studiendesign&amp;diff=958397&amp;oldid=prev"/>
		<updated>2024-11-19T18:42:15Z</updated>

		<summary type="html">&lt;p&gt;wieso hat das nur mit Medizin zu tun?&lt;/p&gt;
&lt;a href=&quot;https://h.suprapedia.de/w/index.php?title=Statistik_und_Studiendesign&amp;amp;diff=958397&amp;amp;oldid=44153&quot;&gt;Änderungen zeigen&lt;/a&gt;</summary>
		<author><name>Fmrauch</name></author>
	</entry>
	<entry>
		<id>https://h.suprapedia.de/w/index.php?title=Statistik_und_Studiendesign&amp;diff=44153&amp;oldid=prev</id>
		<title>Ossip Groth: Die Seite wurde neu angelegt: „Entstehender Artikel {| class=&quot;wikitable&quot; | | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Siehe auch&#039;&#039;&#039; | align=&quot;left&quot; width=&quot;800&quot; | |- | bgcolor=&quot;#d…“</title>
		<link rel="alternate" type="text/html" href="https://h.suprapedia.de/w/index.php?title=Statistik_und_Studiendesign&amp;diff=44153&amp;oldid=prev"/>
		<updated>2010-04-16T14:33:53Z</updated>

		<summary type="html">&lt;p&gt;Die Seite wurde neu angelegt: „&lt;a href=&quot;/wiki/Datei:Pptpdtjpg1.png&quot; title=&quot;Datei:Pptpdtjpg1.png&quot;&gt;miniatur|Entstehender Artikel&lt;/a&gt; {| class=&amp;quot;wikitable&amp;quot; | | bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Siehe auch&amp;#039;&amp;#039;&amp;#039; | align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot; | |- | bgcolor=&amp;quot;#d…“&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Neue Seite&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[Datei:pptpdtjpg1.png|miniatur|Entstehender Artikel]]&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; |&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Siehe auch&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot; |&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Freie Übersichtsartikel&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot; |&lt;br /&gt;
&amp;lt;ref name=&amp;quot;PMID18755930&amp;quot;&amp;gt;When is a negative phase II trial truly negative? Am J Respir Crit Care Med 178(6):554-5 (2008) PMID 18755930 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15590885&amp;quot;&amp;gt;The ethical conduct of clinical research involving critically ill patients in the United States and Canada: principles and recommendations. Am J Respir Crit Care Med 170(12):1375-84 (2004) PMID 15590885 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15151921&amp;quot;&amp;gt;Positive clinical trials: understand the control group before implementing the result. Am J Respir Crit Care Med 170(3):223-6 (2004) PMID 15151921 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID9424990&amp;quot;&amp;gt;Number needed to treat and relative risk reduction. Ann Intern Med 128(1):72-3 (1998) PMID 9424990 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID7486471&amp;quot;&amp;gt;Discordance between meta-analyses and large-scale randomized, controlled trials. Examples from the management of acute myocardial infarction. Ann Intern Med 123(11):873-7 (1995) PMID 7486471 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID16040886&amp;quot;&amp;gt;Understanding systematic reviews and meta-analysis. Arch Dis Child 90(8):845-8 (2005) PMID 16040886 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15102650&amp;quot;&amp;gt;GRADE: levels of evidence and grades of recommendation. Arch Dis Child 89(5):489 (2004) PMID 15102650 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID7492177&amp;quot;&amp;gt;Statistics from the inside. 16. Multiple regression (2). Arch Dis Child 73(3):270-4 (1995) PMID 7492177 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID8067802&amp;quot;&amp;gt;Statistics from the inside. 13. Probability and decisions. Arch Dis Child 71(1):90-4 (1994) PMID 8067802 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID8333779&amp;quot;&amp;gt;10. Counted data (2). Arch Dis Child 68(6):800-2 (1993) PMID 8333779 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID8481051&amp;quot;&amp;gt;Counted data (1). Arch Dis Child 68(2):246-9 (1993) PMID 8481051 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID1444537&amp;quot;&amp;gt;Statistics from the inside. 7. Regression and correlation. Arch Dis Child 67(10):1306-9 (1992) PMID 1444537 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID1626999&amp;quot;&amp;gt;Statistics from the inside. 6. Data structures (continued). Arch Dis Child 67(6):757-9 (1992) PMID 1626999 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17296672&amp;quot;&amp;gt;Documenting research in scientific articles: Guidelines for authors: 3. Reporting multivariate analyses. Chest 131(2):628-32 (2007) PMID 17296672 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17218594&amp;quot;&amp;gt;Documenting research in scientific articles: guidelines for authors: 2. Reporting hypothesis tests. Chest 131(1):317-9 (2007) PMID 17218594 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17035466&amp;quot;&amp;gt;Documenting research in scientific articles: guidelines for authors: reporting research designs and activities. Chest 130(4):1263-8 (2006) PMID 17035466 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID11948065&amp;quot;&amp;gt;The design of randomized clinical trials in critically ill patients. Chest 121(4):1290-300 (2002) PMID 11948065 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID10988210&amp;quot;&amp;gt;Reality and meta-analyses. Chest 118(3):835-6 (2000) PMID 10988210 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID10988209&amp;quot;&amp;gt;Is meta-analysis a metaphysical or a scientific method? Chest 118(3):832-4 (2000) PMID 10988209 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID10453885&amp;quot;&amp;gt;Is meta-analysis really meta-physics? Chest 116(2):539-42 (1999) PMID 10453885 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID12386142&amp;quot;&amp;gt;Advice on statistical analysis for Circulation Research. Circ Res 91(8):662-71 (2002) PMID 12386142 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18981315&amp;quot;&amp;gt;A primer in longitudinal data analysis. Circulation 118(19):2005-10 (2008) PMID 18981315 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18711024&amp;quot;&amp;gt;Some old and some new statistical tools for outcomes research. Circulation 118(8):872-84 (2008) PMID 18711024 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18519862&amp;quot;&amp;gt;Survival methods: additional topics. Circulation 117(22):2949-55 (2008) PMID 18519862 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18506018&amp;quot;&amp;gt;Methods and limitations of assessing new noninvasive tests: Part II: Outcomes-based validation and reliability assessment of noninvasive testing. Circulation 117(21):2793-801 (2008) PMID 18506018 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18490536&amp;quot;&amp;gt;Methods and limitations of assessing new noninvasive tests: part I: Anatomy-based validation of noninvasive testing. Circulation 117(20):2684-90 (2008) PMID 18490536 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18458181&amp;quot;&amp;gt;Logistic regression. Circulation 117(18):2395-9 (2008) PMID 18458181 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18378626&amp;quot;&amp;gt;Multiple linear regression: accounting for multiple simultaneous determinants of a continuous dependent variable. Circulation 117(13):1732-7 (2008) PMID 18378626 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18172051&amp;quot;&amp;gt;Analysis of variance. Circulation 117(1):115-21 (2008) PMID 18172051 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17965399&amp;quot;&amp;gt;Association studies in an era of too much information: clinical analysis of new biomarker and genetic data. Circulation 116(17):1866-70 (2007) PMID 17965399 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17893285&amp;quot;&amp;gt;What exactly do the trends mean? Circulation 116(13):1437-9 (2007) PMID 17893285 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17548743&amp;quot;&amp;gt;Meta-analysis. Circulation 115(22):2870-5 (2007) PMID 17548743 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17404173&amp;quot;&amp;gt;Evaluation of randomized controlled trials. Circulation 115(13):1819-22 (2007) PMID 17404173 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17339574&amp;quot;&amp;gt;Design of randomized controlled trials. Circulation 115(9):1164-9 (2007) PMID 17339574 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17309939&amp;quot;&amp;gt;Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115(7):928-35 (2007) PMID 17309939 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17283280&amp;quot;&amp;gt;Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation 115(5):654-7 (2007) PMID 17283280 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17200454&amp;quot;&amp;gt;Survival methods. Circulation 115(1):109-13 (2007) PMID 17200454 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID16365198&amp;quot;&amp;gt;Standards for statistical models used for public reporting of health outcomes: an American Heart Association Scientific Statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group: cosponsored by the Council on Epidemiology and Prevention and the Stroke Council. Endorsed by the American College of Cardiology Foundation. Circulation 113(3):456-62 (2006) PMID 16365198 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15173053&amp;quot;&amp;gt;The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis. Circulation 109(21):e305-7 (2004) PMID 15173053 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15173052&amp;quot;&amp;gt;The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design. Circulation 109(21):e302-4 (2004) PMID 15173052 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18728215&amp;quot;&amp;gt;Interpreting results of clinical trials: a conceptual framework. Clin J Am Soc Nephrol 3(5):1246-52 (2008) PMID 18728215 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18178786&amp;quot;&amp;gt;Systematic review and meta-analysis: when one study is just not enough. Clin J Am Soc Nephrol 3(1):253-60 (2008) PMID 18178786 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17699379&amp;quot;&amp;gt;Practice recommendations based on low, very low, and missing evidence. Clin J Am Soc Nephrol 2(1):11-2 (2007) PMID 17699379 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17699334&amp;quot;&amp;gt;Cohort studies: marching forward. Clin J Am Soc Nephrol 1(5):1117-23 (2006) PMID 17699334 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17107979&amp;quot;&amp;gt;The meta-analysis: supportive or illuminating? Eur Heart J 27(23):2744-5 (2006) PMID 17107979 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID16870690&amp;quot;&amp;gt;Progress and problems for randomized clinical trials: from streptomycin to the era of megatrials. Eur Heart J 27(18):2158-64 (2006) PMID 16870690 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID16785246&amp;quot;&amp;gt;Limitations of analyses of effectiveness using observational data. Eur Heart J 27(14):1642-3 (2006) PMID 16785246 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15253985&amp;quot;&amp;gt;Interpretation of observational studies. Heart 90(8):956-60 (2004) PMID 15253985 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID11302989&amp;quot;&amp;gt;Absolute, attributable, and relative risk in the management of coronary heart disease. Heart 85(5):491-2 (2001) PMID 11302989 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15985692&amp;quot;&amp;gt;Statistical issues in the analysis of neuronal data. J Neurophysiol 94(1):8-25 (2005) PMID 15985692 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18097119&amp;quot;&amp;gt;The Bayesian clinician. J Postgrad Med 53(4):267-9 (2007) PMID 18097119 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID7996506&amp;quot;&amp;gt;Statistics in medical research--III. Correlation and regression analysis. J Postgrad Med 39(4):235-43 (1993) PMID 7996506 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17652297&amp;quot;&amp;gt;Data extraction errors in meta-analyses that use standardized mean differences. JAMA 298(4):430-7 (2007) PMID 17652297 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID12038922&amp;quot;&amp;gt;How statistical expertise is used in medical research. JAMA 287(21):2817-20 (2002) PMID 12038922 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID11497536&amp;quot;&amp;gt;Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 286(7):821-30 (2001) PMID 11497536 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID9676681&amp;quot;&amp;gt;Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals. JAMA 280(3):278-80 (1998) PMID 9676681 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID9551387&amp;quot;&amp;gt;Meta-analysis as a clinical tool in nephrology. Kidney Int 53(4):819-25 (1998) PMID 9551387 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18182407&amp;quot;&amp;gt;Clinical research of kidney diseases IV: Standard regression models. Nephrol Dial Transplant 23(2):475-82 (2008) PMID 18182407 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17332213&amp;quot;&amp;gt;P less than .05: what does it really mean? Pediatrics 119(3):608-10 (2007) PMID 17332213 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID11884693&amp;quot;&amp;gt;Data and models determine treatment proposals--an illustration from meta-analysis. Postgrad Med J 78(917):131-4 (2002) PMID 11884693 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID11222834&amp;quot;&amp;gt;Balancing statistical and clinical significance in evaluating treatment effects. Postgrad Med J 77(905):201-4 (2001) PMID 11222834 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID10211346&amp;quot;&amp;gt;Statistics in medicine: some considerations from a clinician&amp;#039;s point of view. Postgrad Med J 74(876):577-8 (1998) PMID 10211346 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID10662865&amp;quot;&amp;gt;Potential bias in Kaplan-Meier survival analysis applied to rheumatology drug studies. Rheumatology (Oxford) 39(1):1-2 (2000) PMID 10662865 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID16059787&amp;quot;&amp;gt;When should you use statistics? Swiss Med Wkly 135(23-24):337-8 (2005) PMID 16059787 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID14655052&amp;quot;&amp;gt;Statistics in medical research. Swiss Med Wkly 133(39-40):522-9 (2003) PMID 14655052 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID14655051&amp;quot;&amp;gt;Statistics in medicine. Swiss Med Wkly 133(39-40):521 (2003) PMID 14655051 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID1877042&amp;quot;&amp;gt;Statistics in respiratory medicine. 3. Scale, parametric methods, and transformations. Thorax 46(7):536-8 (1991) PMID 1877042 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID1858087&amp;quot;&amp;gt;Statistics in respiratory medicine. 2. Repeatability and method comparison. Thorax 46(6):454-6 (1991) PMID 1858087 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15483190&amp;quot;&amp;gt;A statistical evaluation of toxicity study designs for the estimation of the benchmark dose in continuous endpoints. Toxicol Sci 84(1):167-85 (2005) PMID 15483190 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID11353128&amp;quot;&amp;gt;Statistical issues in the analysis of low-dose endocrine disruptor data. Toxicol Sci 61(2):201-10 (2001) PMID 11353128 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17058242&amp;quot;&amp;gt;Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies. Hepatology 44(5):1075-82 (2006) PMID 17058242 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID8666350&amp;quot;&amp;gt;Meta-analysis: an introduction and point of view. Hepatology 23(4):917-28 (1996) PMID 8666350 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18617074&amp;quot;&amp;gt;Meta-analysis. J Am Coll Cardiol 52(3):237-8 (2008) PMID 18617074 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15172393&amp;quot;&amp;gt;Prior convictions: Bayesian approaches to the analysis and interpretation of clinical megatrials. J Am Coll Cardiol 43(11):1929-39 (2004) PMID 15172393 &amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Wichtige Übersichtsartikel&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Medline Suchterm/ Synonyme&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#00dfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Was ist das&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Struktur&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Physiologie&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Knockout&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Transgen&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Mutation&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Polymorphismus&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Genexpression&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Inhibitoren&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Agonisten&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
== Bibliographie ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{LinkWP_Miniartikel|Txt=Statistik und Studiendesign|Link=}}&lt;/div&gt;</summary>
		<author><name>Ossip Groth</name></author>
	</entry>
</feed>